Review Article

Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Table 2

Results of sensitivity analysis.

Study excludedHR (95% CI)

Yoshida et al. 20080.56 (0.45–0.70)0.0%0.695
Zhou et al. 20150.54 (0.41–0.70)0.0%0.733
Sohn et al. 20160.60 (0.48–0.74)0.0%0.802
Xu et al. 20140.58 (0.46–0.73)0.0%0.644
Zhu et al. 20150.56 (0.45–0.70)0.0%0.669
Toyoda et al. 20120.59 (0.47–0.73)0.0%0.775

HR: hazard ratio.